Trial
NCT01427322
Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Virginia Commonwealth University
Collaborators
—
Condition
Epithelial Cancer
Intervention
Lapatinib
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-08